2m 2m 2m 2m 2m 2m 2m
Intuitive Surgic (ISRG)
NASDAQ
$403.95+$1.00 (+0.25%)
Price as of Jun 23, 2026 5:37 PM EDT- $142.7BMarket Cap
- -21.77%1-Year Change
- Medical Instruments & SuppliesIndustry
Intuitive Surgic (ISRG)
$403.95+$1.00 (+0.25%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.5B -70.38% | 8.4B +17.24% | 7.1B +14.49% | 6.2B +8.97% | |
Cost of Revenue | 2.9B +5.45% | 2.7B +13.50% | 2.4B +18.18% | 2.0B +15.68% | |
Gross Profit | 6.6B +17.89% | 5.6B +19.13% | 4.7B +12.71% | 4.2B +6.00% | |
Sales and Marketing Expense | 2.4B +11.45% | 2.1B +8.97% | 2.0B +12.87% | 1.7B +18.64% | |
Research and Development Expense | -1.3B +14.54% | -1.1B +14.67% | -998.8M +13.63% | -879.0M +31.00% | |
Depreciation and Amortization Expense | 13.2M -20.96% | 16.7M -17.33% | 20.2M -27.34% | 27.8M +1.46% | |
Total Operating Expenses | 3.7B +12.53% | 3.3B +10.89% | 3.0B +13.13% | 2.6B +22.52% | |
Operating Profit | 2.9B +25.40% | 2.3B +32.95% | 1.8B +12.03% | 1.6B -13.39% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 365.9M +12.62% | 324.9M +69.13% | 192.1M +546.80% | 29.7M -57.14% | |
Income before Taxes | 3.3B +23.85% | 2.7B +36.49% | 2.0B +21.91% | 1.6B -15.00% | |
Income Taxes | 434.8M +29.29% | 336.3M +137.50% | 141.6M -46.04% | 262.4M +61.78% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 2.9B +22.97% | 2.3B +29.18% | 1.8B +35.98% | 1.3B -22.43% | |
Net Income from Continuing Operations Applicable to Common | 3.3B +23.85% | 2.7B +36.49% | 2.0B +21.91% | 1.6B -15.00% | |
Basic EPS and Net Income | 8.00 +22.32% | 6.54 +27.73% | 5.12 +37.63% | 3.72 -22.34% | |
Diluted EPS and Net Income | 7.87 +22.59% | 6.42 +27.63% | 5.03 +37.81% | 3.65 -21.67% | |
Basic Weighted Average Shares | 356.9M +0.48% | 355.2M +1.14% | 351.2M -1.27% | 355.7M -0.11% | |
Diluted Weighted Average Shares | 362.7M +0.19% | 362.0M +1.29% | 357.4M -1.27% | 362.0M -1.04% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.4B +66.12% | 2.0B -26.28% | 2.8B +73.92% | 1.6B +22.49% | |
Short-Term Investments | 2.6B +29.26% | 2.0B -19.70% | 2.5B -2.51% | 2.5B -12.92% | |
Cash and Cash Equivalents and Short-Term Investments | 5.9B +47.88% | 4.0B -23.16% | 5.2B +26.84% | 4.1B -2.05% | |
Total Current Assets | 9.8B +37.53% | 7.1B -9.85% | 7.9B +26.15% | 6.3B +6.98% | |
Accumulated Depreciation | 2.3B +21.01% | 1.9B +20.44% | 1.6B +26.18% | 1.2B +27.80% | |
Property and Plant and Equipment and Net | 5.3B +14.97% | 4.6B +31.35% | 3.5B +49.00% | 2.4B +26.53% | |
Total Long-Term Assets | 8.4B -10.82% | 9.5B +67.31% | 5.7B +13.20% | 5.0B -20.57% | |
Total Assets | 20.5B +9.15% | 18.7B +21.38% | 15.4B +19.02% | 13.0B -4.29% | |
Income Taxes Payable | 319.0M -18.91% | 393.4M +13.96% | 345.2M -10.13% | 384.1M +3.61% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.0B +14.95% | 1.7B +5.22% | 1.7B +16.64% | 1.4B +23.68% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 510.8M +9.08% | 468.3M +21.48% | 385.5M -12.25% | 439.3M -3.17% | |
Total Liabilities | 2.5B +13.71% | 2.2B +8.29% | 2.0B +9.82% | 1.9B +16.08% | |
Retained Earnings | 7.0B +3.06% | 6.8B +43.44% | 4.7B +35.51% | 3.5B -26.48% | |
Total Stockholders Equity | 17.8B +8.46% | 16.4B +23.49% | 13.3B +20.52% | 11.0B -7.22% | |
Total Shares Outstanding | 355.1M -0.42% | 356.6M +1.22% | 352.3M +0.66% | 350.0M -2.15% | |
Cash Flow | |||||
Cash from Operating Activities | 3.0B +25.49% | 2.4B +33.15% | 1.8B +21.67% | 1.5B -28.65% | |
Capital Expenditures | 539.8M -51.42% | 1.1B +4.42% | 1.1B +99.89% | 532.4M +50.61% | |
Cash from Investing Activities | 665.8M +120.34% | -3.3B +808.86% | -360.1M -126.27% | 1.4B +155.69% | |
Dividends Paid | 0 -100.00% | 8.0M N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -2.4B -1,666.67% | 150.9M +152.47% | -287.6M -88.82% | -2.6B -6,082.09% | |
Financials Ratio | |||||
Gross Margin | -15.86% -123.52% | 67.46% +1.61% | 66.39% -1.56% | 67.44% -2.72% | |
Operating Margin | 119.07% +323.39% | 28.12% +13.40% | 24.80% -2.15% | 25.35% -20.52% | |
Return on Assets | 14.57% +7.23% | 13.59% +7.38% | 12.66% +26.95% | 9.97% -27.71% | |
Return on Equity | 16.67% +6.75% | 15.62% +5.76% | 14.77% +28.12% | 11.53% -26.86% | |
Revenue Growth | -70.38% -508.31% | 17.24% +18.92% | 14.49% +61.62% | 8.97% -71.08% | |
Current Ratio | 4.87 +19.64% | 4.07 -14.32% | 4.76 +8.15% | 4.40 -13.50% | |
Cash Ratio | 1.68 +44.52% | 1.16 -29.94% | 1.66 +49.11% | 1.11 -0.96% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow